Goodwin, Latham Lead Biotech Kardigan's $400M IPO
By Jade Martinez-Pogue · June 18, 2026, 4:29 PM EDT
Venture-backed Kardigan Inc., a biotechnology firm developing therapies for cardiovascular diseases, hit the public markets on Thursday after raising $400 million in its initial public offering....
To view the full article, register now.